Medical News
Commercial Launch Announcement Marks a New Chapter for NRx Pharmaceuticals, Inc. (N A S D A Q: NRXP) — FDA-Approved Preservative-Free Ketamine Now Being Sold, 17-Person National Sales Team Activated, Market Relationships Cover Approximately 80% of U.S. Ke
Board-certified diagnostic radiologist and MR safety specialist joins as a Founding Member
The new treatment option is being introduced through OncoBeta's partnership with Greek medical technology company, Mediray
NRx Pharmaceuticals, Inc. (N A S D A Q: NRXP) $NRXP Also Received an $11 Million Dollar Award for Robotic Magnetic Stimulation with Pharma Treatment for Resistant Depression
A Landmark October 30th FDA Approval, Commercial Manufacturing Readiness, Two-Year Stability Results, and an $11.25 Million DARPA Research Contract Put NRx Pharmaceuticals, Inc. (N A S D A Q: NRXP) at an Important Turning Point in Its Growth
Dr. Humble presents The Science of Skin Longevity. Founder and CEO of KLOTHO SKIN discusses the Klotho longevity protein, regenerative skincare, clinical research, and the future of health.
$SNNC acquires Majority Stake in New Joint Venture With Doc-Rx Opens the Door to Telehealth, U.S.-Made Peptides and an Ambitious Wellness Clinic Expansion Strategy
RALEIGH, N.C. - -- The News & Observer's annual awards recognize Preston Dermatology as Best Dermatologist and Best Medical Practice, and Dr. Solomon as Best Doctor. Preston Dermatology & Skin Surgery Center and its founder, board-certified...
Mr Hospital Bed highlights selected Hill Rom hospital beds as leading value options for home care hospital beds in 2026. Refurbished Advanta 2, VersaCare and Progressa models combine hospital-grade construction, powered positioning and mattress choices to
Used medical equipment company Hospital Direct Medical Equipment is seeing contiued growth in the used and refurbished medical equipment sales as hospitals and surgery centers increase looking for used medical equipment options. As a medical equipment ven
NRXP Reports Three Successfully Manufactured Commercial Lots, Two-Year Stability Data, and Commercially Releasable Supply Pending FDA Approval — While an $11.18 Million DARPA Contract Expands the Company's Research Opportunities
October 15 FDA Update Confirms Minor Labeling Changes Ahead of November 10 Goal Date, While an $11.18 Million DARPA Contract and Innovative Depression Research Expand the Company's Potential
Healthcare technology and executive respondents cite integration, automation and cost reduction among key enterprise priorities
HSS Medical Supply honors its top sales team for a year of outstanding performance, strong partnerships, and customer success.
Dr. William Arden joins a team of 17 experienced dentists and dental specialists at Pearlfection Dentistry, a highly rated dental practice in Frederick, MD. Together, the team is committed to providing the highest level of root canal treatment and advance
Women-owned healthcare company marks 11 years by recognizing nine women leaders and contributing $11,000 to Women in Medicine® in support of its inaugural Fellowship
Today's landmark defense contract launches the FDA-approved SPARC-TMS trial while NRx simultaneously advances its preservative-free ketamine program, HOPE Therapeutics and an expanding CNS pipeline
As fentanyl continues to drive an enormous public-health challenge in the United States, Nutriband's AVERSA™ technology is being developed to address a different but important piece of the problem: abuse, misuse, diversion and accidental exposure involvin
Therapeutic massage practice with decades of neuromuscular expertise expands to Santa Monica with its second Southern California location.
Veteran trauma surgeon brings decades of military and civilian critical-care experience back to Cincinnati, with a continued focus on trauma systems, emergency preparedness, and care for older adults.
$NTRB reaches a new 52-week high of $9.00 and closes at $8.99, extending a powerful September advance as the company approaches the September 30 expiration of 910,904 publicly traded warrants and continues advancing its AVERSA™ abuse-deterrent transdermal